Canary Capital’s staked Injective ETF gets its launch details
Canary Capital (
@CanaryFunds) has moved its planned staked Injective ETF to Nasdaq under the ticker INJC, in a fourth amended filing with the SEC on Friday. The fund would hold $INJ and stake at least 90% of it, charge a 1.10% yearly fee, and pay 30% of its staking rewards in staking fees.
The Injective Foundation plans to buy up to $15M of shares at the start, paid in INJ, and Jane Street, Cumberland, and Flowdesk are among the fund’s named trading partners. The fund cannot begin trading until the SEC signs off.